Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...

Pfizer said on Thursday its hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant ...

Long-term follow-up data show that the preventive effects of short-term treatment with abatacept disappear after 4-5 years.

Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...

Help is now there for those diagnosed with hard-to-treat blood cancers like leukemia and lymphoma, as new therapies are ...

Patients with bronchiectasis and a Pseudomonas aeruginosa infection receiving gremubamab, a bispecific monoclonal antibody, ...

Elanco Animal Health Incorporated announced today that its Canine Parvovirus Monoclonal Antibody (CPMA) has become the first US Department of Agriculture conditionally approved treatment that targets ...